CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale President and CEO sold 147,000 shares at $12.00 ($1,764,000)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes COO and SVP, Compliance gave up 3,177 shares (to pay taxes)
- 4 Grant or award CFO and Treasurer acquired 85,130 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 6,400 shares at $7.91 ($50,624)
- 4 Open-market buy Director bought 12,500 shares at $8.01 ($100,125)
- 4 Open-market buy Director bought 12,500 shares at $8.01 ($100,125)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
Page 1 of 50 · 1,000 filings